Device Trial Radar · NCT06261788
Efficacy and Safety of the Sync-AV II Temporary Cardiac Pacing Catheter
Last checked: Nov 20, 2026Latest source record: Feb 15, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
30
Actual
Start
Jun 1, 2023
Primary completion
Sep 13, 2023
Study completion Sep 26, 2023
Sponsor
- Lead sponsor
- Swift Sync, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Regulatory and Quality Solutions
- First posted
- Feb 15, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Supportive care
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, single-center, non-randomized open label study. The objective of this study is to evaluate the efficacy and safety of the Sync-AV II Temporary Cardiac Pacing Catheter in subjects whose elective surgical or interventional procedure require temporary pacing support.
Conditions
- Heart Block
- Valve Heart Disease
Interventions
Temporary pacingDevice
Transvenous temporary cardiac pacing - right internal jugular insertion
Primary outcomes
What the sponsor says the trial is designed to measure.
- With a commercially available pacing box and/or analyzer, measure the ventricular pacing threshold at 24 hours post implant of the investigational device (index procedure)Time frame: 24 hours post implant
- Procedure related complicationsTime frame: through study completion, an average of 7 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Centro de Intervenciones Endovasculares y Cirugia Cardiovascular
Asunción, Paraguay
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.